Triglyceride-Rich Lipoprotein Cholesterol, Small Dense LDL Cholesterol, and Incident Cardiovascular Disease

Edward K Duran1, Aaron W Aday2, Nancy R Cook3

  • 1Division of Preventive Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. Electronic address: https://twitter.com/EKDuranMD.

Insights

Triglyceride-rich lipoprotein cholesterol (TRL-C) and small-dense LDL cholesterol (sdLDL-C) predict cardiovascular disease risk. TRL-C is linked to myocardial infarction and PAD, while sdLDL-C is associated with MI, highlighting their independent roles in atherogenesis.

Area of Science:

  • Cardiovascular Medicine
  • Lipid Metabolism
  • Atherosclerosis Research

Background:

  • Elevated triglyceride-rich lipoprotein (TRL) and small-dense low-density lipoprotein (sdLDL) cholesterol are linked to atherogenic dyslipidemia.
  • Their cholesterol content is hypothesized to drive atherosclerotic risk, but data in primary prevention are limited.

Purpose of the Study:

  • To prospectively evaluate associations between TRL cholesterol (TRL-C) and sdLDL cholesterol (sdLDL-C) concentrations and incident cardiovascular disease (CVD).
  • To assess associations with composite CVD outcomes and individual events including myocardial infarction (MI), ischemic stroke (IS), and peripheral artery disease (PAD).

Main Methods:

  • A prospective case-cohort study within the Women's Health Study.
  • Direct measurement of TRL-C and sdLDL-C in baseline blood samples.
  • Risk associations evaluated for composite and individual CVD outcomes, adjusted for traditional risk factors.

Main Results:

  • Both TRL-C and sdLDL-C quartiles significantly increased the risk of composite CVD outcomes.
  • TRL-C was significantly associated with MI and PAD; sdLDL-C was significantly associated with MI.
  • Both markers showed weak associations with IS, and similar patterns were observed for continuous exposures.

Conclusions:

  • TRL-C strongly associates with future MI and PAD events.
  • sdLDL-C strongly associates with MI alone.
  • These findings suggest TRL-C and sdLDL-C cholesterol influence atherogenesis independently of LDL-C and hs-CRP.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
504
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.2K
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
1.2K
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
530
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
263
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
660